Focus Stocks
Bulls in Charge of Merck
Published on Thursday, 09 September 2010 01:54 Written by Christopher Lynn
New York, September 9th (TradersHuddle.com) - Shares of Merck & Co. Inc. (NYSE:MRK) ended the trading
session higher by $0.35 or 0.99% from its previous close. Merck's price action formed what is considered to be a
bullish engulfing candle that could very well signal continuation of trend or reversal on ongoing weakness.
Merck & Co., Inc. (NYSE:MRK), the global pharmaceutical company that develops, manufactures, and markets a broad range of human and animal health products. Merck's products include Zocor for treatment of elevated cholesterol, Propecia for treatment for male pattern hair loss, Fosamax for preventive treatment of osteoporosis, and Singulair for treatment of asthma. Merck was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Merck's recent stock range has been formed by a trough where calculated support was defined at $34.41 and by a peak that established the resistance level at $35.84, which could be used by traders planning their trades.
Traders wanting to establish a position in Merck or traders that are already holding the stock can use the bullish engulfing pattern to their advantage. The pattern provides a defined risk as it shows where the bears were able to push the stock down, before the bulls stepped in.
The bullish engulfing pattern is a leading indicator that provides an alert to the bulls that the trend will continue or that there is an immediate reversal to the short term weakness seen on the stock. Below an Engulfing Bullish Candle Illustration:

Related Articles
- Thomas E. Shenk To Retire From Merck's Board of Directors
- Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar
- Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia
- Approaching Resistance - Merck
- Bank of America - Top Performing Dow Component
- Research Analyst's Up/Downgrades ( APKT, BRCD, CVC, KMX, HVB, LINTA, AGP, MRK, IP )
- Bears Appeared - Merck
- FDA Approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of JANUMET® (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience
- Dow's Top Performers :AA, BAC, AXP
- Stocks Tread Water on Mixed Earnings and Bernanke Testimony
Related Partner Headlines
- Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar - Benzinga
- Merck Confirms Plans to File NDA for Suvorexant in 2012 - Benzinga
- FDA Approves JANUMET XR for Type 2 Diabetes - Benzinga
- Dow Today: Merck (MRK) Lower - TheStreet.com
- Merck, Pfizer: Dow Midday Movers - TheStreet.com
- UPDATE: Merck Swings To Q4 Profit - Benzinga
- Merck's Earnings Are Up, But a Huge Drop may be Coming - Benzinga
- Merck Beats, Expects Flat 2012 Adjusted EPS - TheStreet.com
- Dow Today: Merck (MRK) Leads The Day Higher, Travelers Companies (TRV) Lags - TheStreet.com
- Merck Stock Hits New 52-Week High (MRK) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga -
'Fast Money' Recap: Cisco's Back - TheStreet.com -
Benzinga's M&A Chatter for Wednesday February 8, 2012 - Benzinga -
Market Preview: Fearing the Inevitable Pullback - TheStreet.com -
Mike Khouw's OpenTable Inc Trade - Benzinga -
Fast Money Picks For February 9th - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
Comstock Mining Announces Pricing of Public Offering of Common Stock -
Boeing 787 Dreamliner Debuts in Bangkok for Dream Tour -
SYNC Accelerates into 2013 as Standard Equipment on New Ford Fusion and Flex -
Bacteria Detection Time Cut From Days to Minutes -
Pantone Announces Fashion Color Report Fall 2012 -
Analog Devices’ Webcast Addresses How To Select The Right Differential ADC Driver For Your Design: Part Two -
EpiCept to Raise $2 Million in Registered Direct Offering -
The Eco Picture Diary Global Contest Ceremony and Partnership Press Event held at the UNESCO Headquarters










